デフォルト表紙
市場調査レポート
商品コード
1622354

タンパク質シーケンス市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025~2032年

Protein Sequencing Market Size, Share, Growth Analysis, By Product (Protein Sequencing Products, Protein Sequencing Services), By Application (Biomarker Discovery, Protein Engineering Studies), By End-User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 242 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
タンパク質シーケンス市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2025~2032年
出版日: 2024年12月23日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

タンパク質シーケンス市場規模は2023年に13億4,000万米ドルと評価され、2024年の13億9,000万米ドルから2032年には17億5,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは3.5%で成長する見通しです。

タンパク質シーケンス市場は、質量分析によってアミノ酸配列を解読するde novoシーケンシングにおける重要な役割によって、力強い成長を遂げています。このハイスループットなプロテオミクス技術は、バイオテクノロジー企業や製薬企業が先進国市場や新興国市場において標的治療薬の開発に注力していることが大きく影響して、標的ベースの創薬において支持を集めています。プロテオミクス研究への資金提供の増加は、医薬品開発におけるタンパク質バイオマーカーの需要の高まりを反映し、この分野をさらに強化しています。製薬業界やバイオテクノロジー業界がターゲットに基づいた投薬設計を採用する傾向が強まっていることから、同市場は今後も拡大が見込まれます。さらに、タンパク質配列技術の進歩と遺伝子組み換え生物に関する進行中の研究により、遺伝子工学への応用が強化され、業界の将来の成長が促進される可能性があります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • ケーススタディ

タンパク質シーケンス市場規模:製品・サービス別

  • 市場概要
  • タンパク質シーケンス製品
    • 試薬・消耗品
    • 機器
    • 質量分析
    • エドマン劣化
    • ソフトウェア
  • タンパク質シーケンスサービス
    • サンプル調製サービス
    • シーケンシングサービス
    • データ分析サービス

タンパク質シーケンス市場規模:用途別

  • 市場概要
  • バイオマーカーの発見
  • タンパク質工学研究
  • バイオ医薬品
  • その他
    • 構造生物学
    • 創薬

タンパク質シーケンス市場規模:エンドユーザー別

  • 市場概要
  • 製薬・バイオテクノロジー企業
  • 研究センター
  • 学術機関
  • その他
    • 契約調査機関(CRO)
    • 診断検査室

タンパク質シーケンス市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Thermo Fisher Scientific Inc.(USA)
  • Agilent Technologies, Inc.(USA)
  • Bioinformatics Solutions Inc.(Canada)
  • Shimadzu Corporation(Japan)
  • Waters Corporation(USA)
  • Bruker Corporation(USA)
  • Danaher Corporation(USA)
  • PerkinElmer, Inc.(USA)
  • Charles River Laboratories International, Inc.(USA)
  • QIAGEN N.V.(Netherlands)
  • Merck KGaA(Germany)
  • GenScript Biotech Corporation(China)
  • Creative Proteomics(USA)
  • Bio-Rad Laboratories, Inc.(USA)
  • Promega Corporation(USA)
  • Pacific Biosciences of California, Inc.(USA)
  • Oxford Nanopore Technologies Ltd.(UK)
  • Illumina, Inc.(USA)
  • Becton, Dickinson and Company(USA)
  • Eurofins Scientific(Luxembourg)

結論と推奨事項

目次
Product Code: SQSG35H2025

Protein Sequencing Market size was valued at USD 1.34 Billion in 2023 and is poised to grow from USD 1.39 Billion in 2024 to USD 1.75 Billion by 2032, growing at a CAGR of 3.5% during the forecast period (2025-2032).

The protein sequencing market is experiencing robust growth, driven by its vital role in de novo sequencing, which deciphers amino acid sequences via mass spectrometry. This high-throughput proteomic technique has gained traction in target-based drug discovery, significantly influenced by the intensified focus of biotechnology and pharmaceutical companies on developing targeted therapies across developed and emerging markets. Increased funding for proteomics research further bolsters this sector, reflecting a heightened demand for protein biomarkers in drug development. As the pharmaceutical and biotechnology industries increasingly adopt target-based medication design, the market is poised for continued expansion. Moreover, advancements in protein sequencing technology and ongoing research into genetically modified organisms will likely enhance its application in genetic engineering, propelling future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Sequencing Market Segmental Analysis

Global Protein Sequencing Market is segmented by product, application, end-user and region. Based on product, the market is segmented into protein sequencing products and protein sequencing services. Based on application, the market is segmented into biomarker discovery, protein engineering studies, biotherapeutics and others. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research centers, academic institutions and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Sequencing Market

The Protein Sequencing market is set to experience significant growth driven by several technological advancements. Key among these is the enhancement of clinical mass spectrometry and analytical techniques, which are expected to facilitate more accurate and efficient protein analysis. Additionally, the increasing financial support from both public and private sectors for proteome research is anticipated to significantly contribute to the expansion of this market. This combination of improved technologies and bolstered funding will likely create a favorable environment for innovation and development within the protein sequencing sector, thus propelling market growth throughout the forecast period.

Restraints in the Protein Sequencing Market

One of the significant challenges hindering the growth of the Protein Sequencing market is the high cost associated with the necessary infrastructure. This financial burden poses a considerable barrier to market expansion during the forecast period. Furthermore, the demand for highly skilled researchers and laboratory personnel also restricts growth potential, as specialized expertise is essential for effective protein sequencing. Additionally, the complexities involved in generating pure protein samples contribute to the overall limitations facing the market. Collectively, these factors create a restrictive environment that may slow down advancements and innovation within the Protein Sequencing landscape.

Market Trends of the Protein Sequencing Market

The protein sequencing market is experiencing significant growth driven by advancements in protein engineering, particularly the incorporation of unnatural amino acids (uAA). This trend enables site-specific conjugation of functional moieties, enhancing the effectiveness of therapeutic drugs, including antibodies and vaccines. As bioformulations dominate the pharmaceutical landscape, the demand for precise and efficient protein characterization tools is surging. Furthermore, innovations in post-translational engineering and strain development are accelerating biopharmaceutical approvals, making the market more dynamic. With a focus on developing better-defined protein products, the protein sequencing market is poised for substantial expansion in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Protein Sequencing Market Size by Product & Service & CAGR (2025-2032)

  • Market Overview
  • Protein Sequencing Products
    • Reagents & Consumables
    • Instruments
    • Mass Spectrometry
    • Edman Degradation
    • Software
  • Protein Sequencing Services
    • Sample Preparation Services
    • Sequencing Services
    • Data Analysis Services

Global Protein Sequencing Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Biomarker Discovery
  • Protein Engineering Studies
  • Biotherapeutics
  • Others
    • Structural Biology
    • Drug Discovery

Global Protein Sequencing Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical & Biotechnology Companies
  • Research Centers
  • Academic Institutions
  • Others
    • Contract Research Organizations (CROs)
    • Diagnostic Laboratories

Global Protein Sequencing Market Size & CAGR (2025-2032)

  • North America (Product & Service, Application, End-User)
    • US
    • Canada
  • Europe (Product & Service, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product & Service, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product & Service, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product & Service, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioinformatics Solutions Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript Biotech Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Proteomics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations